BCM
BMY.RT
Beddow Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
522,789
-29,750
| -5% | – | ﹤0.01% | 57 |
|
|
2025
Q1 | $0 | Sell |
552,539
-1,250
| -0.2% | – | ﹤0.01% | 59 |
|
|
2024
Q4 | $0 | Hold |
553,789
| – | – | ﹤0.01% | 59 |
|
|
2024
Q3 | $0 | Hold |
553,789
| – | – | ﹤0.01% | 60 |
|
|
2024
Q2 | $0 | Sell |
553,789
-7,000
| -1% | – | ﹤0.01% | 59 |
|
|
2024
Q1 | $0 | Hold |
560,789
| – | – | ﹤0.01% | 60 |
|
|
2023
Q4 | $0 | Sell |
560,789
-1,750
| -0.3% | – | ﹤0.01% | 58 |
|
|
2023
Q3 | $0 | Sell |
562,539
-8,590
| -2% | – | ﹤0.01% | 55 |
|
|
2023
Q2 | $0 | Hold |
571,129
| – | – | ﹤0.01% | 54 |
|
|
2023
Q1 | $0 | Hold |
571,129
| – | – | ﹤0.01% | 54 |
|
|
2022
Q4 | $0 | Sell |
571,129
-1,750
| -0.3% | – | ﹤0.01% | 52 |
|
|
2022
Q3 | $0 | Hold |
572,879
| – | – | ﹤0.01% | 51 |
|
|
2022
Q2 | $0 | Hold |
572,879
| – | – | ﹤0.01% | 54 |
|
|
2022
Q1 | $0 | Buy |
572,879
+357,579
| +166% | – | ﹤0.01% | 57 |
|
|
2021
Q4 | $0 | Sell |
215,300
-354,989
| -62% | – | ﹤0.01% | 52 |
|
|
2021
Q3 | $0 | Hold |
570,289
| – | – | ﹤0.01% | 57 |
|
|
2021
Q2 | $0 | Sell |
570,289
-1,500
| -0.3% | – | ﹤0.01% | 60 |
|
|
2021
Q1 | $0 | Hold |
571,789
| – | – | ﹤0.01% | 59 |
|
|
2020
Q4 | $395K | Buy |
571,789
+43,006
| +8% | +$29.7K | 0.28% | 40 |
|
|
2020
Q3 | $1.19M | Buy |
528,783
+50,925
| +11% | +$115K | 1.02% | 26 |
|
|
2020
Q2 | $1.68M | Sell |
477,858
-16,025
| -3% | -$56.2K | 1.47% | 26 |
|
|
2020
Q1 | $1.91M | Buy |
+493,883
| New | +$1.91M | 1.75% | 25 |
|